Table 4.
Parameters | Formulations
|
||
---|---|---|---|
GPS powder | GPS-NLCs | GPS-SGC-NLCs | |
| |||
Tmax (h) | 0.792±0.102 | 1.417±0.276* | 2.250±0.212*,** |
Cmax (µg/mL) | 0.455±0.080 | 0.671±0.073* | 0.859±0.113*,** |
AUC0–∞ (µg/mL·h) | 1.355±0.407 | 4.591±0.668* | 11.491±0.707*,** |
MRT0–∞ (h) | 6.224±0.341 | 11.832±1.413 | 21.589±1.267*,** |
Notes:
P<0.05, vs GPS powder.
P<0.05, vs GPS NLCs. Data are represented as mean ± SD.
Abbreviations: GPS, gypenosides; SGC, sodium glycocholate; NLCs, nanostructured lipid carriers. Tmax, time peak plasma concentration; Cmax, peak plasma concentration; AUC0–∞, area under the plasma concentration time curve; MRT0–∞, mean retention time.